-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
DaVita Inc. (NYSE:DVA) Shares Sold by Bank of New York Mellon Corp
DaVita Inc. (NYSE:DVA) Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp lessened its holdings in shares of DaVita Inc. (NYSE:DVA – Get Rating) by 5.7% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 573,063 shares of the company's stock after selling 34,852 shares during the quarter. Bank of New York Mellon Corp owned 0.64% of DaVita worth $47,432,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Ellevest Inc. increased its position in DaVita by 1,388.0% during the 3rd quarter. Ellevest Inc. now owns 372 shares of the company's stock worth $31,000 after purchasing an additional 347 shares in the last quarter. Eisler Capital UK Ltd. acquired a new stake in DaVita during the 3rd quarter worth approximately $35,000. Parkside Financial Bank & Trust grew its position in DaVita by 88.6% in the first quarter. Parkside Financial Bank & Trust now owns 313 shares of the company's stock valued at $35,000 after acquiring an additional 147 shares in the last quarter. Neo Ivy Capital Management acquired a new stake in DaVita in the third quarter valued at approximately $40,000. Finally, Wipfli Financial Advisors LLC acquired a new stake in DaVita in the third quarter valued at approximately $44,000. Institutional investors and hedge funds own 86.52% of the company's stock.
Get DaVita alerts:DaVita Stock Performance
DaVita stock opened at $76.12 on Friday. The stock has a 50 day moving average of $80.61 and a 200-day moving average of $80.17. DaVita Inc. has a 52 week low of $65.28 and a 52 week high of $124.81. The stock has a market cap of $6.88 billion, a P/E ratio of 13.17, a price-to-earnings-growth ratio of 1.57 and a beta of 0.95. The company has a current ratio of 1.20, a quick ratio of 1.16 and a debt-to-equity ratio of 9.92.
DaVita (NYSE:DVA – Get Rating) last announced its quarterly earnings data on Wednesday, February 22nd. The company reported $1.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.23. DaVita had a return on equity of 74.02% and a net margin of 4.83%. The firm had revenue of $2.92 billion for the quarter, compared to analysts' expectations of $2.93 billion. During the same period last year, the business posted $2.02 earnings per share. The firm's revenue for the quarter was down .9% on a year-over-year basis. On average, analysts expect that DaVita Inc. will post 5.93 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several analysts have issued reports on DVA shares. StockNews.com started coverage on shares of DaVita in a research report on Thursday, March 16th. They issued a "buy" rating for the company. Truist Financial increased their price objective on shares of DaVita from $84.00 to $90.00 and gave the company a "hold" rating in a research report on Thursday, February 23rd. Sanford C. Bernstein started coverage on shares of DaVita in a research report on Tuesday, March 7th. They issued a "market perform" rating for the company. Cowen increased their price objective on shares of DaVita from $76.00 to $90.00 and gave the company an "outperform" rating in a research report on Thursday, February 23rd. Finally, Deutsche Bank Aktiengesellschaft increased their target price on DaVita from $72.00 to $85.00 in a research note on Thursday, February 23rd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $86.43.
Insider Buying and Selling
In related news, Director Charles Berg sold 1,431 shares of the firm's stock in a transaction on Thursday, March 9th. The stock was sold at an average price of $75.13, for a total transaction of $107,511.03. Following the transaction, the director now directly owns 15,733 shares in the company, valued at $1,182,020.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.00% of the stock is currently owned by company insiders.
DaVita Company Profile
(Get Rating)
DaVita, Inc engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure.
Featured Articles
- Get a free copy of the StockNews.com research report on DaVita (DVA)
- Dividend King Genuine Parts Company Upgraded On Profit Guidance
- The Bottom Is In For Accenture
- 11 Best Consumer Discretionary Stocks of 2023
- 5 Best Dividend Capture Stocks
- 10 Best Consumer Discretionary ETFs
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.
紐約梅隆銀行(Bank of New York Mellon Corp.)在最近提交給美國證券交易委員會的檔案中稱,該公司第三季度減持了5.7%的DaVita Inc.股票。該機構投資者在本季度出售了34,852股後,持有該公司573,063股股票。截至最近提交給美國證券交易委員會的檔案,紐約梅隆銀行持有DaVita 0.64%的股份,價值47,432,000美元。
其他機構投資者和對沖基金最近也買賣了該公司的股票。Ellevest Inc.在第三季度將其在DaVita的頭寸增加了1388.0%。Ellevest Inc.現在持有372股該公司股票,價值3.1萬美元,上個季度又購買了347股。艾斯勒資本英國有限公司在第三季度收購了DaVita價值約3.5萬美元的新股份。第一季度,Parkside Financial Bank&Trust在DaVita的頭寸增加了88.6%。Parkside Financial Bank&Trust現在擁有該公司313股股票,價值3.5萬美元,上個季度又購買了147股。Neo Ivy Capital Management在第三季度收購了DaVita的新股份,價值約為40,000美元。最後,Wipfli Financial Advisors LLC在第三季度收購了DaVita的新股份,價值約為4.4萬美元。機構投資者和對沖基金持有該公司86.52%的股票。
到達達維塔警報:達維塔股票表現
DaVita的股票週五開盤報76.12美元。該股的50日移動均線切入位在80.61美元,200日移動均線切入位在80.17美元。DaVita Inc.的股價為52周低點65.28美元,52周高點為124.81美元。該股市值為68.8億美元,本益比為13.17倍,本益比為1.57倍,貝塔係數為0.95。該公司的流動比率為1.20,速動比率為1.16,債務權益比率為9.92。
DaVita(紐約證券交易所代碼:DVA-GET Rating)最近一次公佈季度收益數據是在2月22日星期三。該公司公佈本季度每股收益(EPS)為1.11美元,比普遍預期的0.88美元高出0.23美元。DaVita的股本回報率為74.02%,淨利潤率為4.83%。該公司當季營收為29.2億美元,高於分析師預期的29.3億美元。去年同期,該業務公佈的每股收益為2.02美元。該公司本季度的收入同比下降了0.9%。分析師平均預計,DaVita Inc.本財年每股收益將達到5.93歐元。
分析師升級和下調評級
幾位分析師已經發布了關於DVA股票的報告。StockNews.com在3月16日星期四的一份研究報告中開始對DaVita的股票進行報道。他們對該公司的評級為“買入”。Truist Financial在2月23日星期四的一份研究報告中將DaVita的股票目標價從84.00美元上調至90.00美元,並給予該公司“持有”評級。桑福德·C·伯恩斯坦在3月7日星期二的一份研究報告中開始報道DaVita的股票。他們對該公司進行了“市場表現”評級。考恩在2月23日(星期四)的一份研究報告中將DaVita的股票目標價從76.00美元上調至90.00美元,並給予該公司“跑贏大盤”的評級。最後,德意志銀行Aktiengesellschaft在2月23日星期四的一份研究報告中將DaVita的目標價從72.00美元上調至85.00美元。一名股票研究分析師將該股評級為賣出,5名分析師給予持有評級,兩名分析師給予該股買入評級。根據MarketBeat.com的數據,該股目前的平均評級為持有,共識目標價為86.43美元。
內幕買賣
在相關新聞中,董事查爾斯·伯格在3月9日星期四的一次交易中出售了1,431股該公司的股票。該股以75.13美元的平均價格出售,總成交金額為107,511.03美元。交易完成後,董事現在直接擁有該公司15,733股股份,價值1182,020.29美元。這筆交易是在提交給美國證券交易委員會的一份檔案中披露的,該檔案可通過美國證券交易委員會網站。1.00%的股份目前由公司內部人士持有。
DaVita公司簡介
(獲取評級)
DaVita,Inc.從事醫療保健服務的提供。它通過以下兩個部門運作:美國透析和相關實驗室服務,以及其他輔助服務和戰略倡議。美國透析及相關實驗室服務部門在美國為慢性腎功能衰竭患者提供腎臟透析服務。
專題文章
- 免費獲取StockNews.com關於DaVita(DVA)的研究報告
- 紅利王正品配件公司利潤指引升級
- 埃森哲的底部已經到了
- 2023年11只最佳非必需消費品股票
- 5只最佳股利捕捉股
- 十大最佳消費者可自由支配ETF
接受《達維塔日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對DaVita和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧